New model of neuronal circuit provides insight on eye movement

Working with week-old zebrafish larva, researchers at Weill Cornell Medicine and colleagues decoded how the connections formed by a network of neurons in the brainstem guide the fishes’ gaze.

$1.6M supports land-grant research for NY farms, forests, communities

Fifty-four research projects addressing New York’s agriculture, environment and communities have collectively received $1.6 million from the USDA.

Key strategies unveiled against drug-resistant prostate cancer

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine.

Stretching shapes and building tools: topology at Cornell

Cornell has been responsible for many milestones in the field of topology.

Around Cornell

Race-blind college admissions harm diversity without improving quality

 A new study by Cornell information science researchers finds that ignoring race in college admissions leads to an admitted class that is much less diverse, but with similar academic credentials to those where affirmative action is factored in.

As US craft beer industry goes flat, NYS bubbles with optimism

In 2023, craft beer production in the U.S. declined by 1%, which is the worst on record since the Brewers Association began tracking the industry in the late 1970s. New York fared better.

Mini smart city drives design of safer automated transportation

The Information and Decision Science Laboratory is designing a better – and safer – future for transportation with the help of a 20-by-20-foot “smart” scaled city and a fleet of motorized cars, drones and virtual reality technology.

Idea thieves tend to target early concepts

People who steal ideas from creative workers prefer to do so in earlier conceptual stages than creators expect, according to new Cornell research.

For-profit hospices increasing despite poor performance

Hospices are increasingly owned by private equity firms and publicly traded companies, but recently Weill Cornell Medicine researchers found that they performed substantially worse than hospices owned by not-for-profit agencies.